Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

OGEN stock hub

Oragenics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

OGENis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.6M

NYSEAMERICAN

Market data

Live price

Current market quote for this ticker.

Current price

OGEN

In the news

Latest news · OGEN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-311

P25 -105.6P50 -46.5P75 -3.1

ROIC-134.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All OGEN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

183

Groups with data

Currency

USD

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001174940
Company name	Oragenics, Inc.
Country	United States
Country code	US
Cusip	684023609
Employees	3
Employees Change	-2%
Employees Change Percent	-40
Enterprise value	$-3.5M
Exchange	NYSEAMERICAN
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US6840236094
Last refreshed	2026-05-10
Market cap	$2.6M
Market cap category	Nano-Cap
Price	$0.6
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	OGEN
Website	https://www.oragenics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-379.61%
FCF yield	-360.62%
P/B ratio	0.42x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-2.4M
Net Income	$-9.8M
Net Income Growth Quarters	2%
Net Income Growth Years	2%
Profit Per Employee	$-3.3M
ROA	-105.6
Roa5y	-104.6
ROCE	-155.2
ROE	-311
Roe5y	-271.8
ROIC	-134.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-63.81%
Cagr15y	-54.35%
Cagr1y	-88.31%
Cagr20y	-46.94%
Cagr3y	-80.39%
Cagr5y	-78.13%
EPS Growth Quarters	1
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$7.5M
Cash	$6.1M
Current Assets	$7.5M
Current Liabilities	$1.3M
Debt	$56,134
Debt Equity	$0.01
Equity	$6.2M
Interest Coverage	-16.24
Liabilities	$1.3M
Long Term Assets	$0
Long Term Liabilities	$0
Net Cash	$6.1M
Net Cash By Market Cap	$234
Net Cash Growth	598.16%
Net Debt Equity	$-0.98
Tangible Book Value	$6.2M
Tangible Book Value Per Share	$1.41
WACC	28.57

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.73
Net Working Capital	$130,814
Quick ratio	4.67
Working Capital	$6.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-797.06%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-100%
1Y total return	-88.3%
200-day SMA	0.96
3Y total return	-99.25%
50-day SMA	0.7
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.95%
All Time High	1,800,180
All Time High Change	-100%
All Time High Date	2003-09-05
All Time Low	0.5
All Time Low Change	18.5%
All Time Low Date	2026-03-30
ATR	0.05
Beta	1.26
Beta1y	2.06
Beta2y	2.13
Ch YTD	-23.77
High	0.63
High52	9.6
High52 Date	2025-06-02
High52ch	-93.78%
Low	0.59
Low52	0.5
Low52 Date	2026-03-31
Low52ch	18.5%
Ma50ch	-14.13%
Premarket Change Percent	-2.1
Premarket Price	$0.6
Premarket Volume	3,262
Price vs 200-day SMA	-38.01%
RSI	42.2
RSI Monthly	32
RSI Weekly	33.91
Sharpe ratio	-1.29x
Sortino ratio	-1.59
Total Return	-797.06%
Tr YTD	-23.77
Tr15y	-100%
Tr1m	5.29%
Tr1w	-3.71%
Tr3m	-18.44%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-9.6M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,236,603%
Float Percent	97.71%
Net Borrowing	-3,076,829
Shares Insiders	0.39%
Shares Institutions	6.52%
Shares Out	4,336,029
Shares Qo Q	1.58%
Shares Yo Y	797.06%
Short Float	16.6%
Short Ratio	7.22
Short Shares	16.22

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-10.1M
Average Volume	54,036.85x
Bv Per Share	1.41
Ch10y	-100
Ch15y	-100
Ch1m	5.29
Ch1w	-3.71
Ch1y	-88.3
Ch20y	-100
Ch3m	-18.44
Ch3y	-99.25
Ch5y	-99.95
Ch6m	-46.55
Change	-2.61%
Change From Open	-4.02
Close	0.61
Days Gap	1.47
Dollar Volume	37,507.1
Earnings Date	2026-05-08
Earnings Time	amc
EBIT	$-9.6M
EPS	$-3.19
F Score	2
FCF	$-9.3M
FCF EV Yield	269.61x
FCF Per Share	$-2.15
Financing CF	12,020,941
Fiscal Year End	December
Founded	1,996
Income Tax	$-159,535
Investing CF	4,000,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Last Split Date	2025-06-03
Last Split Type	Reverse
Last10k Filing Date	2026-03-16
Ma150	0.88
Ma150ch	-32.09%
Ma20	0.64
Ma20ch	-7.2%
Net CF	6,686,000
Next Earnings Date	2026-08-07
Open	0.62
Optionable	No
Position In Range	24.64
Post Close	0.6
Postmarket Change Percent	3.82
Postmarket Price	$0.62
Pre Close	0.61
Price Date	2026-05-08
Ptbv Ratio	0.42
Relative Volume	1.16x
Share Based Comp	773,037
Tr20y	-100%
Tr6m	-46.57%
Us State	Florida
Volume	62,826

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does OGEN pay a dividend?

Capital-return profile for this ticker.

Performance

OGEN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns OGEN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.5%

Float: +97.7% of shares outstanding

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

OGEN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.2

Neutral momentum band

Price vs 200-day MA

-38.0%

50/200-day relationship not available

Beta (5Y)

1.26

More volatile than the market

Sharpe ratio

-1.29

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About OGEN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current OGEN stock rating?

Oragenics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full OGEN analysis?

The full report lives at /stocks/OGEN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for OGEN?

The latest report frames OGEN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the OGEN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.